Target intelligence / Profile preview

Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (ASAP1)

Target
ASAP1
Molecular classification
Enzyme, GTPase-activating protein, Scaffold protein
01

Overview

Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (ASAP1, also commonly known as AMAP1) is a multidomain ADP-ribosylation factor (Arf) GTPase-activating protein (GAP) that plays a pivotal role in regulating membrane trafficking, receptor recycling, and actin cytoskeleton remodeling. It possesses GAP activity stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2), primarily targeting ARF1 and ARF5, and to a lesser extent ARF6. In cancer, AMAP1 is frequently overexpressed and acts as a critical downstream effector of the ARF6 pathway, where it forms a trimeric complex with cortactin and paxillin at invadopodia to drive extracellular matrix degradation, tumor cell invasion, and metastasis. Additionally, AMAP1 regulates the recycling of integrins and immune checkpoint proteins like PD-L1, contributing to immune evasion and drug resistance in various malignancies, including breast, pancreatic, and lung cancers. Pharmacological targeting of AMAP1 has been explored using small-molecule inhibitors like the broad-spectrum ARFGAP inhibitor QS11, the SH3-domain blocker UCS15A, and cell-permeable peptidomimetics like P4-TAT, which disrupt its interaction with cortactin to suppress metastatic progression.

Other names
AMAP1DDEF1DEF-1PAG2PAPCENTB4ZG14PKIAA1249Development and differentiation-enhancing factor 1130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating proteinADP-ribosylation factor-directed GTPase-activating protein 1PIP2-dependent ARF1 GAP
02

Mechanism of action

Inhibition of ARFGAP catalytic activity or disruption of atypical protein-protein interactions (such as AMAP1-cortactin or AMAP1-CIN85 binding) to block downstream signaling, receptor recycling, and cytoskeletal remodeling.

03

Biological functions

Signal transductionCell migrationCell invasionCytoskeleton remodelingMembrane traffickingReceptor recycling
04

Disease associations

CancerInfectionTuberculosis
05

Safety considerations

Impaired immune cell motilityIncreased susceptibility to tuberculosisPotential off-target effects on normal membrane trafficking and ciliogenesis
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

AMAP1 protein expressionASAP1 gene amplificationPD-L1 expressionHIF-1α expressionCAIX expression

Beyond the preview

Go deeper on Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (ASAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (ASAP1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call